Single Patient Compassionate Use Treatment of Refractory Epstein-Barr Virus (EBV) Infection and Post-transplant Lymphoproliferative Disease (PTLD) with Related Donor EBV Specific Cytotoxic T Lymphocytes (CTL)
| Protocol No. | PHO-IIR-28059 | Scope | Local |
|---|---|---|---|
| Principal Investigator | Scott Goebel | Treatment Type | Treatment |
| Age Group | Adults and Children | Phase | NA |
